The HHCL Division of Hetero Healthcare is focused on providing therapeutic solutions across anti-infective care and the management of bacterial, fungal, and other infection-related conditions. The division aims to support healthcare professionals with dependable treatment options for infections encountered across different clinical settings, helping address both routine and more complex patient-care requirements.

Its therapeutic portfolio encompasses key areas such as antibacterial and antifungal therapy, respiratory tract infections, urinary tract infections, gastrointestinal infections, and other infectious conditions. Through a range of established anti-infective therapies and supportive treatment options, HHCL strives to enable effective clinical management while addressing the diverse needs of patients with infection-related illnesses.

Backed by Hetero Healthcare’s commitment to quality, accessibility, innovation, and patient-centric care, the HHCL Division continues to contribute to the evolving landscape of infection management. With its focused anti-infective portfolio, the division aims to support healthcare professionals in delivering appropriate treatment and contribute to improved patient care and clinical outcomes.